Medtech, Pharma, Life Sciences, & Biotech Companies

A Path to Investment Success

Discover the Power of
Regulation A+, D 506(c), CF

If you are looking to raise up to $75M using Regulation A+,
don’t miss out on this opportunity to be part of a financial revolution.

Book a FREE Call to get a Capital Raising Consultation and get access to our exclusive fundraising resources: 

• CPVS™ White Papers
• CPVS™ Sample Documents
• Video Presentation on Funding Strategies

Get Access to CPVS™ Resources

Schedule a Call & Get FREE Access to Our Exclusive CPVS™ Resources:
Presentation Video, White Papers, and Sample Documents. 

Video Presentation on Funding

CPVS™ White Papers

CPVS™ Sample Documents

You are an owner of a medtech, pharma, life sciences, or biotech company and you want to raise up to $75 million without sacrificing control to outside investors.
But…


• You are having trouble choosing a fundraising strategy that aligns with
your business goals, timing constraints, and liquidity needs

• You have questions about Blue Sky Laws and how to navigate the complex
regulatory requirements of a capital raise

• You are confused about the various types of Regulation Offerings
and how they differ from traditional methods of raising capital



Rest assured, the experts at CPVS™ are here to assist you in finding solutions to the capital raising issues you might face as a business owner. Whatever the stage of your company – product development, clinical trials, post-approval, commercialization, or expansion – we’ll design a fundraising strategy that fits your needs.

With over 22 years of experience providing capital planning and advisory services for startups and mid-market private and public companies, we come equipped with all the tools to meet your fundraising and capital market objectives.


How Capital Planning Valuation Strategy™
Can Help You



CPVS™ – Capital Planning Valuation Strategy™ is a 6 week process designed to help business owners like you decide whether a Regulation A+ offering, a 506(c), or a CF is right for them. The process establishes a powerful foundation for decisions about your company’s future capital funding efforts and provides a path to maintain control of your company while building a blueprint for a successful offering.


We developed a comprehensive assessment that will inform you about the JOBS Act and how to capitalize on the unique advantages of Regulation A+, 506(c), and CF which include access to a wider capital market and more diverse investor community, the potential to raise significant capital without sacrificing control, a simpler and more streamlined fundraising process, monetization opportunities, lower compliance burden, and above all, lower cost to you.

Our CPVS™ Assessment is the easiest and most efficient way for companies to determine their funding requirements and identify the optimal method of raising capital.

But before going any further, we’d like to share with you our video presentation on funding strategies as well as our educational white papers and sample documents, all of which you can access for free by scheduling a call with us. This is the first step on your fundraising journey with Regulation A+, 506c, and CF, and the first step towards unlocking your full capital raising potential.

Client Testimonials

CPVS™ is the best capital raising analytics service on the market, and it’s the only one tailored specifically to healthcare companies like yours. But don’t just take our word for it…

“Medical Funding Professionals’ comprehensive approach to capital planning has been instrumental in shaping our fundraising strategy. The 1.5-hour presentation they delivered was particularly beneficial as it outlined several funding paths that could save us time and money compared to more conventional routes. Just as important, the strategies they proposed were tailored specifically to our funding needs and goals, resulting in a customized plan that exceeded our expectations.

We are now much better prepared to make capital raising decisions. I would recommend Medical Funding Professionals and their CPVS™ Process to any business owner or organization looking to raise capital.

RS BioTherapeutics
Curtis Rhine

CFO, RS BioTherapeutics


* [The above statement is provided from the client of the advisor. There has been no compensation paid of any type or kind in exchange for the statement. No material conflicts of interest exist arising from the relationship between the advisor and the client. The statements provided may not be indicative of all client experiences. There can be no performance guarantees or guarantees of success.]

Since launching Manhattan Stret Capital in 2015, I’ve worked with hundreds of companies wanting to raise capital, and the fact of the matter is, most of them simply aren’t prepared—not that their business isn’t a good candidate for raising money, but they just aren’t ready in terms of founder knowledge, corporate organization, capitalization, presentation, and marketing.

That’s why I’m very impressed by what Stephen Brock has brought to the table. His Capital Planning Valuation Strategy™ is a systematic, progressive approach following the best practices of capital raising. He invests the time in educating them on corporate structure, the various types of fundraising opportunities and what’s appropriate for them. Understanding securities is complex, and Stephen has a wealth of knowledge to share with founders.

Manhattan Street Capital
Rod Turner

CEO, Manhattan Street Capital


* [The above statement is provided by an advisor to the firm who is not currently nor has ever been a client of the firm. There has been no compensation paid of any type or kind in exchange for the statement. No material conflicts of interest exist arising from the relationship between the advisor and the client. The statements provided may not be indicative of all client experiences. There can be no performance guarantees or guarantees of success.]

What’s Next…?

Only 3 Steps

1

CHOOSE YOUR DATE & TIME

2

CHECK YOUR EMAIL INBOX

3

ACCESS TO RESOURCE PAGE